Maintenance treatments for opiate dependent adolescent

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2009, Pages

  Minozzi, Silvia ^a   Amato, Laura ^a   Davoli, Marina ^a  

^a ASL RM/E   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; CANNABIS; COCAINE; DIAMORPHINE; LEVACETYLMETHADOL; LYSERGIDE; METHADONE; OPIATE;

CHILD HEALTH CARE; CLINICAL TRIAL; COCHRANE LIBRARY; DETOXIFICATION; DRUG DOSE REDUCTION; DRUG EFFICACY; FOLLOW UP; HEADACHE; HEALTH STATUS; HUMAN; INHALANT ABUSE; MAINTENANCE THERAPY; MEDLINE; METHODOLOGY; OPIATE ADDICTION; OUTCOME ASSESSMENT; PSYCHOSOCIAL CARE; REVIEW; SOCIAL STATUS; SUBSTANCE ABUSE; TREATMENT OUTCOME;

EID: 70349147471     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007210.pub2     Document Type: Review

References (35)

1. Lehmann WX. The use of 1-alpha-acetyl-methadol (LAAM) as compared to methadone in the maintenance and detoxification of young heroin addicts. NIDA monograph 1973;8:82-83
2. Woody GE, Poole SA, Subramanian G, Dugosh K, Bogenschutz M, Abbott P, et al. Extended vs short term buprenorphine-naloxone for treatment of opioid addicted youth. a randomised trial. JAMA 2008;300(17):2003-2011
3. Baer JS, Garret SB, Beadnell B, Wells EA, Peterson PL. Brief motivational intervention with homeless adolescents: evaluating effects on substance use and service utilization. Psychology of Addictive Behaviors 2007;21(4):582-586
4. Ebner R, Zierer C, Schreiber W. After detoxification is before tetoxification? Long term outcome of drug dependent adolescent [Nach dem Entzug=vor demEntzug? Langzeitvrlauf bei drogenabhangigen Jugendlichen]. Psychiatr Prax 2007;34(suppl. 1):s42-3.
5. Forcehimes AA, Bogenschutz MP, Tonigan JS, Woody GE. Impact of therapeutic alliance on treatment outcome in opioid dependent adolescent and young adult treated with buprenorphine. Proceedings of the 70th Annual Scientific Meeting of the College on Problems of Drug Dependence. Puerto Rico. 2008.
6. Godley SH, Dennis ML, Godely MD, Funk RR. Thirty-months relapse trajectory cluster groups among adolescents discharged from out-patients teratment. Addiction 2004;99(suppl. 2):129-139
7. Kemp R, Harris A, Vurel E, Siharthan T. Stop using stuff: trial of a drug and alcohol intervention for young people with comorbid mental illness and drug and alcohol problems. Australasian Psychiatry 2007;15(6):490-493 (Pubitemid 350120847)
8. Lloyd RA, Katon RN, DuPont RL. Evolution of a treatment approach for young heroin addicts. Comparison of three treatment modalities. The International Journal of Addiction 1974;9(2):229-239
9. Marsch LA, Bickel WK, Badger GJ, Stothart ME, Quesnel KJ, Stanger C, et al. Comparison of pharmacological treatments for opioid- dependent adolescents. Archives of General Psychiatry 2005;62:1157-1164
10. Marsch L. Science based treatment for opioid dependent adolescent. www.clinicaltrials.gov. NCT00182572 2005.
11. Australian Institute of Health and Welfare. Statistics on drug use in Australia 2006. Drug Statistics Series No.18 Cat.no. PHE 80 Canberra: AIHW.. Available at: http://www.aihw.gov.au/ 2007.
12. Altobelli E, Rapacchietta L, Tiberti S, Petrocelli R, Cicioni L, di Orio F, et al. Association between drug, alcohol and tobacco use in adolescents and social-familiar factors [Associazione tra l'uso di sostanze stupefacenti, alcol e tabacco negli adolescenti e contesto socio-familiare]. Annali d'Igiene 2005;17:57-65.
13. Amato L, Minozzi S, Davoli M, Vecchi S, Ferri M, Mayet S. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD004147]
14. Clark N, Lintzeris N, Gijsbers A, Whelan G, Ritter A, Dunlop A. LAAM maintenance versus methadone maintenance for heroin dependence. Cochrane Database of Systematic Reviews 2002, Issue 2. [DOI: DOI: 10.1002/14651858. CD002210]
15. Dortmizer CM, Gonzalez GB, Penna M, Bejarano J, Obando P, Sanchez M, et al. The PACARDO research project: youthful drug involvement in Central Amrica and the Dominican Republi. Rev Panam Salud Publica 2004;15(6):400-416 (Pubitemid 38988999)
16. European Monitoring Centre for Drugd & Drug Addiction (EMCDDA). Annual Report: The state of the drugs problem. European Union and Norway. Office for publications of the European Communities, Luxembourg 2008.
17. European School Survey Project on Alcohol and Other Drugs (ESPAD). Available at: http://www.epid.ifc.cnr.it/Espad 2006.
18. Faggiano F, Vigna-Taglianti F, Versino E, Lemma P. Methadone maintenance at different dosages for opioid dependence. Cochrane Database of Systematic Reviews 2003, Issue 3. [DOI: 10.1002/14651858.CD002208]
19. Ferri M, Davoli M, Perucci CA. Heroin maintenance for chronic heroin dependent. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD003410]
20. Galanter M, Glickman L, DSinger D. An overview of outpatient treatment of adolescent substance abuse. Substance Abuse 2007;28(2):51-58 (Pubitemid 47300812)
21. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org Version 5.0.0 [updated February 2008].
22. Hopfer CJ, Khurl E, Crowley TJ, Hooks S. Adolescent heroin use: a reviewof the descriptive and treatment literature. Journal of Substance abuse Treatment 2002;23(3):231-237 (Pubitemid 35254166)
23. Hunt RD, Capper L, O'Connel P. Clonidine in child and adolescent psychiatry. Journal of Child Adolescent Psychofarmacology 1990;1:87-102.
24. Kaminer Y. Pharmacotherapy for adolescents with psychoactive substance use disorders. NIDA Research Monograph 1995;156:291-324.
25. Kellogg S, Melia D, Khuri E, Lin A, Ho A, Kreek MJ. Adolescent and young adult heroin patients: drug use and success in methadone maintenance treatment. Journal of addictive Diseases 2006;25:15-25. (Pubitemid 44352899)
26. Lobmaier PP, Kornør H, Kunøe N, Bjørndal A. Sustained-Release Naltrexone For Opioid Dependence. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD004330]
27. Marsch LA, Bickel WK, Badger GJ, Stothart ME. Comparison of pharmacological treatments for opioid dependent adolescents. Archives of General Psychiatry 2005;62(10):1157-1164
28. Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews 2003, Issue 2. [DOI: 10.1002/14651858.CD002209] (Pubitemid 351807246)
29. Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD002207] (Pubitemid 351807246)
30. Mayet S, Farrell M, Ferri M, Amato L, Davoli M. Psychosocial treatment for opiate abuse and dependence. Cochrane Database of Systematic Reviews 2004, Issue 4. [DOI: 10.1002/14651858.CD004330]
31. Millman RB, Khuri ET, Nyswander ME. Therapeutic detoxification of adolescent heroin addicts. Annals of the New York Academy of Science 1978;311:153-164
32. Minozzi S, Amato L, Vecchi S, Davoli M, Kirchmayer U, Verster A. Oral naltrexone maintenance treatment for opioid dependence. Cochrane Database of Systematic Reviews 2006, Issue 1. [DOI: 10.1002/14651858.CD001333]
33. Monitoring the Future Study. Available at http://monitoringthefuture.org Accessed 2003..
34. Nealgus A, Attilasoy A, Friedman SR, Andreade X, Miller M, Idelfonso G, et al. Trends in non injected use of heroin and factors associated with the transition to injecting. In: Inciardi JA, Herrison LD editor(s). Heroin in the age of crack cocaine. Thousand Oaks, California, 1998:131-159
35. Results from the 2002 National Survey on Drug use and health: National findings. Substance Abuse and Mental Health Services Admistration (SAMHSA). Office of Applied Studies, NHSDA series H-22, DHHS publication SMA 03-3836. Rockville, MD.